Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 8,503,000 | 8,388,000 | 7,447,000 | 8,196,000 | 6,903,000 |
| Cost of Goods | 3,310,000 | 3,236,000 | 3,200,000 | 3,112,000 | 1,806,000 |
| Gross Profit | 5,193,000 | 5,152,000 | 4,247,000 | 5,084,000 | 5,097,000 |
| Operating Expenses | 3,146,000 | 3,243,000 | 3,256,000 | 3,813,000 | 3,076,000 |
| Operating Income | 2,047,000 | 1,909,000 | 991,000 | 1,271,000 | 2,021,000 |
| Interest Expense | 776,000 | 808,000 | 824,000 | 821,000 | 759,000 |
| Other Income | 1,830,000 | -307,000 | -235,000 | 402,000 | 685,000 |
| Pre-tax Income | 3,101,000 | 794,000 | -68,000 | 852,000 | 1,947,000 |
| Income Tax | 271,000 | 48,000 | 45,000 | 85,000 | 217,000 |
| Net Income Continuous | 2,830,000 | 746,000 | -113,000 | 767,000 | 1,730,000 |
| Net Income | $2,830,000 | $746,000 | $-113,000 | $767,000 | $1,730,000 |
| EPS Basic Total Ops | 5.27 | 1.39 | -0.21 | 1.43 | 3.23 |
| EPS Basic Continuous Ops | 5.27 | 1.39 | -0.21 | 1.42 | 3.23 |
| EPS Diluted Total Ops | 5.22 | 1.38 | -0.21 | 1.42 | 3.22 |
| EPS Diluted Continuous Ops | 5.22 | 1.38 | -0.21 | 1.42 | 3.22 |
| EPS Diluted Before Non-Recurring Items | 5.58 | 4.97 | 3.96 | 4.71 | 4.96 |
| EBITDA(a) | $3,443,000 | $3,309,000 | $2,390,000 | $2,651,000 | $2,916,000 |